About this trial
This study will contribute to the current literature that have compared joint injections with steroid versus ketorolac providing evidence for the use of ketorolac for SI joint pain. Currently steroid is the clinical standard for joint injections, however with repetitive use, steroid injections can damage the joint. Ketorolac is an alternative anti-inflammatory medication that does not cause the same joint damage and at a cheaper cost than steroid. The investigators hypothesize that ultrasound guided SI joint injections utilizing ketorolac provide the same pain relief as corticosteroid SI joint injections measured at 2, 6 and 12 weeks post injection. This would allow more frequent injections to control pain at a decreased cost to the healthcare system.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
SI joint pain for at least 3 months
Age greater than 18
Must have at least 3 special tests positive for SI joint pain on physical exam
Disqualifiers
Previous back surgery
Radicular leg pain
Discogenic pain
Myofascial pain syndrome
Trial design
Crossover
Treatments tested in this trial
Methylprednisolone Injection
DrugMedication will be injected into SI joint under ultrasound guidance
Ketorolac Injection
DrugMedication will be injected into SI joint under ultrasound guidance
Treatment groups
Trial outcomes
Primary outcomes
Sacroiliac (SI) joint pain
SI joint pain at 2, 6 and 12 week marks post SI joint injection measured on visual analogue scale. Higher numbers equate to worse pain and worse outcomes.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.